Eucure Biopharma, a wholly owned subsidiary of Biocytogen, announced the first patient dosing for a phase I multi-r...
IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted anti-cancer ther...
Asieris Pharmaceuticals, a global innovative biopharma company specializing in discovering and developing innovativ...
Pulnovo Medical Limited, a globally recognized OTM innovative platform, recently announced the appointment of Jessie Lia...
Chinese firm Gan & Lee Pharmaceuticals has announced that the first subject has been dosed in our Phase I, double-bl...
The MIKADO group, a translational team at the University of Zurich (UZH) focused on generating evidence-driven...
Researchers from the School of Public Health, LKS Faculty of Medicine of The University of Hong Kong (HKUMed), in collab...
SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, has announced the CE (Conformit&...
Akeso, Inc., a biopharmaceutical company dedicated to the development of innovative antibody drugs, has announced that t...
WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced the launch of Tetracycline-Enabl...
Singleron Biotechnologies, a leading Chinese genomics company that develops groundbreaking single-cell multi-omics platf...
AnchorDx, a world-leading developer of cancer screening and early detection solutions, is delighted to announc...
111, Inc., a leading tech-enabled healthcare platform company in China, has signed a strategic cooperation agreement on ...
China based I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercializa...
InxMed Co., Ltd, a clinical-stage biotechnology startup based in China, has announced that it had completed $5...
Overland Pharmaceuticals, a premier biopharmaceutical company bringing innovative medicines to patients in Asia and worl...
China's Adagene, a company transforming the discovery and development of antibody-based therapies, has announced a...
InnoCare Pharma, a leading biopharmaceutical company, has announced the Investigational New Drug (IND) approval of its B...
